Lymphocyte Populations in Atherosclerotic Lesions of ApoE −/− and LDL Receptor −/− Mice

Arteriosclerosis, Thrombosis, and Vascular Biology - Tập 16 Số 8 - Trang 1013-1018 - 1996
Simon E. Roselaar1, Paul X. Kakkanathu1, Alan Daugherty1
1the Departments of Medicine (S.E.R., P.X.K., A.D.) and Biochemistry and Molecular Biophysics (A.D.), Washington University School of Medicine, St Louis, Mo.

Tóm tắt

Lymphocytes are prominent components of human atherosclerotic lesions, but their presence in murine models of disease has not been confirmed. Lymphocyte subpopulations have been identified in apoE −/− and LDL receptor −/− mice fed a cholesterol-enriched diet for up to 3 months. ApoE −/− mice had higher serum cholesterol concentrations than did LDL receptor −/− mice during most of the feeding period, primarily due to large increases in VLDL concentrations. Total area of atherosclerotic lesions was greater at all times in apoE −/− than LDL receptor −/− mice (lesion area after 3 months on cholesterol-enriched diet: apoE −/−, 993±193 and LDL receptor −/−, 560±131 μm2×103, mean±SEM, n=6 in each group). Lesions in apoE −/− mice contained larger macrophage-rich necrotic cores and more calcification than did those in LDL receptor −/− mice. Immunocytochemical analyses of tissue sections of ascending aortas performed with monoclonal antibodies to T and B lymphocytes and macrophages revealed that T lymphocytes immunoreactive for Thy 1.2, CD5, CD4, and CD8 were observed in lesions from both strains, but no B lymphocytes were detected. The density of Thy 1.2+T lymphocytes in lesions was greatest at 1 month (apoE −/−, 98±23 and LDL receptor −/−, 201±40 lymphocytes/mm2, n=6 in each group), decreasing in apoE −/− mice to 12±3 and in LDL receptor −/− mice to 51±20 lymphocytes/mm2at 3 months. The presence of T lymphocytes in murine atherosclerotic lesions makes these animals potentially useful for studying the involvement of the immune system in atherogenesis.

Từ khóa


Tài liệu tham khảo

Wissler RW and the PDAY Investigators. New insights into the pathogenesis of atherosclerosis as revealed by PDAY. Atherosclerosis . 1994;108(suppl):S3-S20.

10.1161/01.ATV.7.1.9

10.1161/01.ATV.7.1.24

10.1161/01.ATV.4.4.323

10.1161/01.ATV.4.4.341

10.1016/0021-9150(87)90202-4

10.1073/pnas.89.10.4471

10.1172/JCI116663

10.1126/science.1411543

10.1016/0092-8674(92)90362-G

10.1172/JCI117460

10.1161/atv91.14.1.8274468

10.1161/atv91.14.1.8274470

10.1172/JCI117179

10.1161/01.ATV.6.2.131

1988, Am J Pathol, 130, 369

10.1016/0021-9150(88)90074-3

1992, Am J Pathol, 140, 907

10.1016/0090-1229(90)90155-J

10.1016/S0046-8177(87)80168-5

10.1161/atv91.12.2.1531930

1986, Clin Exp Immunol, 64, 261

1989, Am J Pathol, 135, 169

10.1161/atvb.15.11.1995

1991, Lab Invest, 65, 654

10.1073/pnas.92.9.3893

10.1073/pnas.92.11.4937

10.1172/JCI118174

1993, Am J Pathol, 142, 1906

10.1172/JCI117622

10.1161/atv91.14.9.8068611

1991, Coron Artery Dis, 2, 775

1980, J Biol Chem, 255, 1839, 10.1016/S0021-9258(19)85958-6

1980, J Lipid Res, 21, 970, 10.1016/S0022-2275(20)34757-X

10.1172/JCI113633

10.1002/j.1460-2075.1985.tb03886.x

10.1084/jem.152.2.280

10.1002/eji.1830240733

10.1161/atv91.13.6.8499414

10.1172/JCI116605

10.1016/S0008-6363(96)88585-3

10.1161/atv91.11.3.2029509

10.1161/atvb.15.10.1563

1995, Virchows Arch, 426, 307

10.1111/j.1768-322X.1985.tb00368.x

1986, J Immunol, 136, 3716, 10.4049/jimmunol.136.10.3716

10.1016/0008-8749(95)80004-3

10.1083/jcb.97.4.1113

10.1172/JCI116425

1987, J Biol Chem, 262, 11657, 10.1016/S0021-9258(18)60860-9

Thông tin
Thông tin xuất bản

Arteriosclerosis, Thrombosis, and Vascular Biology

Tập 16 Số 8

1013-1018

Thông tin tác giả